GlassScriptPhysician profile
Stephen J Monnig
NPI 1790703007
$17,849.10
in general payments reported to CMS, 2019-2025
42 companies · $3,728 in 2025
The $3,728 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,394 · 2020: $917 · 2021: $1,075 · 2022: $3,296 · 2023: $3,543 · 2024: $3,896 · 2025: $3,728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,271 · Travel and Lodging: $4,895.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,271.21 |
| Travel and Lodging | $4,895.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,247.80 | 2021-2025 | Interstim, Altaviva |
| Teleflex LLC | $2,562.10 | 2021-2025 | Urolift, Barrigel |
| Axonics, INC. | $1,862.29 | 2020-2024 | Axonics, Bulkamid |
| Procept Biorobotics Corporation | $1,823.91 | 2020-2025 | Aquabeam System |
| Astellas Pharma US INC | $910.88 | 2019-2025 | Xtandi |
| Neotract INC. | $671.53 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $442.90 | 2019-2024 | Xiaflex |
| Ferring Pharmaceuticals INC. | $383.13 | 2019-2025 | Adstiladrin |
| Medtronic USA, INC. | $345.61 | 2019-2020 | |
| Abbvie INC. | $335.61 | 2019-2025 | |
| Boston Scientific Corporation | $308.01 | 2019-2025 | Moses 550 Dfl, Lithovue, Axonics |
| Janssen Biotech, INC. | $240.51 | 2019-2025 | Erleada, Akeega |
| Urogen Pharma, INC. | $225.31 | 2025 | |
| Sumitomo Pharma America, INC. | $217.07 | 2025 | Gemtesa, Orgovyx |
| Antares Pharma, INC. | $211.45 | 2019-2024 | Xyosted |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $189.21 | 2025 | Illuccix |
| 180 Medical, INC. | $180.16 | 2019-2021 | |
| Accord Healthcare, INC. | $178.89 | 2023-2025 | |
| Calyxo, INC. | $165.17 | 2025 | Cvac Aspiration System |
| Endo USA, INC. | $149.41 | 2024-2025 | Xiaflex |
| Urovant Sciences INC | $134.35 | 2022 | |
| Myriad Genetic Laboratories, INC. | $121.80 | 2021-2025 | Prolaris |
| Tolmar, INC. | $117.13 | 2024-2025 | Eligard |
| Healthtronics Stone Solutions, LLC | $116.88 | 2025 | Dornier Medtech, Dornier Medtech, Cvac Aspiration System |
| Convatec INC. | $101.87 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $71.72 | 2025 | |
| Olympus America INC. | $63.07 | 2024-2025 | Itind System |
| Zyla Life Sciences, INC. | $57.18 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.39 | 2021-2024 | |
| Verity Pharmaceuticals INC. | $48.54 | 2025 | Trelstar |
| Blue Earth Diagnostics | $47.44 | 2019 | |
| Immunitybio, INC. | $37.51 | 2024 | |
| Halozyme INC | $30.95 | 2023 | |
| Azurity Pharmaceuticals, INC. | $28.76 | 2025 | Azmiro |
| C. R. Bard, INC. & Subsidiaries | $27.77 | 2019 | |
| Coloplast Corp | $27.40 | 2019-2025 | |
| Kowa Pharmaceuticals America, INC. | $21.74 | 2023 | Seglentis |
| Ambu INC. | $21.74 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $21.26 | 2019 | |
| Agiliti Surgical, INC. | $18.07 | 2025 | Koelis Trinity Mri/US Fusion |
| Pfizer INC. | $17.66 | 2024 | |
| Foundation Medicine, INC. | $13.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Monnig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.